United States v. Kareem Memon — Information (S.D. Fla., Dkt. 1)

Summary

A Rule 20 transfer packet entered on the docket January 11, 2024 as Document 1 in Case 0:24-cr-60004-RS in the Southern District of Florida, transferring United States v. Kareem Memon from the District of New Jersey, Criminal No. 24-17 (MEF). It contains Memon's consent to transfer the case for plea and sentence under Fed. R. Crim. P. 20, the New Jersey docket for Case 2:24-cr-00017-MEF-1, and the clerk's transmittal letter dated January 10, 2024. The enclosed information charges conspiracy to commit health care fraud under 18 U.S.C. § 1349 in Count 1 and conspiracy to violate the Federal Anti-Kickback Statute under 18 U.S.C. § 371 in Count 2, alleging that from in or around 2017 through in or around 2020 Memon's companies were paid kickbacks for completed doctor's orders for durable medical equipment billed to Medicare.

Summary drafted by a model from the text of the original file linked on this page and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“United States v. Kareem Memon — Information (S.D. Fla., Dkt. 1).” Original at archive.org. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/rule-20-transfer-packet-incl-no-0-24-cr-60004-dkt-1-s-d-fla-f941b9bba6/, SHA-256 bf666ddf5ab4b443d7b3948b572e8275ceb9c687e3493fab75b21389745fe922.

Full text

Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 1 of 21

Jan 11, 2024

Miami

(MEF)

24-17

SDFL Case # 24-cr-60004 Smith/Augustin-Birch
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 2 of 21
Query Reports Utilities WorkFlow Schedule Help What's New
Log Out

U.S. District Court
District of New Jersey [LIVE] (Newark)
CRIMINAL DOCKET FOR CASE #: 2:24-cr-00017-MEF-1

Case title: USA v. MEMON Date Filed: 01/10/2024

Assigned to: Judge Michael E. Farbiarz

Defendant (1)
KAREEM MEMON represented by BRIAN SILBER
916 SOUTH ANDREWS AVENUE
FORT LAUDERDALE,, FL 33316
1954-462-3636
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: CJA Appointment

Pending Counts Disposition
None

Highest Offense Level (Opening)
None

Terminated Counts Disposition
18-1349 CONSPIRACY TO COMMIT
HEALTH CARE FRAUD (dof- from 2017-
2020)
(1)
18:371 CONSPIRACY TO VIOLATE THE
FEDERAL ANTI-KICKBACK STATUTE
(dof- from 2017-2020)
(2)

Highest Offense Level (Terminated)
Felony

Complaints Disposition
None

Plaintiff
USA represented by MATTHEW SPECHT
DOJ-USAO
DISTRICT OF NEW JERSEY
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 3 of 21
970 BROAD STREET
ROOM 700
NEWARK, NJ 07102
973-353-6061
Email: matthew.specht@usdoj.gov
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Designation: Assistant US Attorney

Date Filed # Docket Text
01/10/2024 1 CONSENT TO TRANSFER JURISDICTION (Rule 20) to SOUTHERN DISTRICT OF
FLORIDA by KAREEM MEMON. (JB, ) (Main Document 1 replaced on 1/10/2024) (JB, ).
(Additional attachment(s) added on 1/10/2024: # 1 Information) (JB, ). (Additional attachment(s)
added on 1/10/2024: # 3 Cover sheet) (JB, ). Modified on 1/10/2024 (mfr). (Entered: 01/10/2024)
01/10/2024 Notice of Allocation and Assignment setting plea agreement hearing as to KAREEM MEMON for
2/20/2024 at 02:00 PM before Judge Michael E. Farbiarz. (JB, ) Modified on 1/10/2024 (JB, ).
(Entered: 01/10/2024)
01/10/2024 Notice of Allocation and Assignment setting plea agreement hearing as to KAREEM MEMON for
2/6/2024 at 02:00 PM before Judge Michael E. Farbiarz. (JB, ) (Entered: 01/10/2024)
01/10/2024 Please disregard the setting of plea hearing as to KAREEM MEMON this case is a Rule 20
Transfer out to Southern District of Florida: (mfr) (Entered: 01/10/2024)
01/10/2024 2 INFORMATION as to KAREEM MEMON (1) count(s) 1, 2. (JB, ) (Entered: 01/10/2024)
01/10/2024 3 Transmittal Letter re: 1 Rule 20 - Transfer Out to the District of Southern Florida. (JB, ) (Entered:
01/10/2024)
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 4 of 21

UNITED STATES DISTRICT COURT
DISTRICT OF NEW JERSEY
OFFICE OF THE CLERK CAMDEN OFFICE
M. L. KING JR. FEDERAL BLDG. & U.S. COURTHOUSE ONE JOHN F. GERRY PLAZA
50 WALNUT STREET, P.O. BOX 419 FOURTH & COOPER STREETS
NEWARK, NJ 07101-0419 CAMDEN, NJ 08101
(973) 645-3730
TRENTON OFFICE
402 EAST STATE STREET
Melissa E. Rhoads ROOM 2020
Clerk TRENTON, NJ 08608

REPLY TO:

January 10, 2024

Re: U.S.A. v- KAREEM MEMONOur
Docket No. 24-cr17 (MEF)

Dear Clerk:

A Consent to Transfer Case pursuant to Rule 20 of the Federal Rules of Criminal
Procedure has been filed with this District in the above-captioned case. This District considers
the electronic record to be the original pursuant to Federal Rules of Criminal Procedure 49(d),
Local Civil Rule 5.2 and paragraph 7 of the Court’s Electronic Case Filing Policies and
Procedures. The original records of this Court can be obtained by accessing CM/ECF through
PACER. Certified copies of any document not available through PACER are enclosed. Kindly
acknowledge receipt on the duplicate of this letter, which is provided for your convenience.

Sincerely,

MELISSA E. RHOADS, Clerk

By: JACKELINE BARCO
Deputy Clerk

RECEIPT ACKNOWLEDGED BY:
DATE:
YOUR DOCKET NUMBER: .

DNJ-Crim-001(Rev. 09/06)
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 5 of 21

Instructions for Retrieving Electronic Case Files

1. Access the CM/ECF website for the District of New Jersey at https://ecf.njd.uscourts.gov

2. Click on: Link to Electronic Filing System (Live)

3. At the ECF/PACER Login Screen, enter your Court’s PACER Login and Password

4. On the CM/ECF toolbar, choose:

• Reports
• Docket Sheet
• Enter Case Number in the following format: [06-1234]
• Run Report

< To view a document from the docket sheet, click on the blue “underlined”
document number;

< To download, click on File, Save a Copy and save to your specific
directory;

< If the document does not have an underlined document number, it is
either:

• A text only entry and no document is attached, or
• An entry made prior to electronic case filing and the original is
enclosed, or
• The document included an attachment too large for the electronic
case filing system and is enclosed.

If you have any questions, our ECF help-desk telephone numbers are as follows:

< Camden - 866-726-0726 or 856-757-5285
< Newark - 866-208-1405 or 973-645-5924
< Trenton - 866-848-6059 or 609-989-2004
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 6 of 21

MHS/2023R00813

UNITED STATES DISTRICT COURT
DISTRICT OF NEW JERSEY

UNITED STATES OF AMERICA : Hon. (MEF)
:
v. : Criminal No. 24-17
:
KAREEM MEMON : 18 U.S.C. § 1349 18
: U.S.C. § 371

INFORMATION

The defendant having waived in open court prosecution by Indictment, the

Attorney for the United States for the District of New Jersey, acting under

authority conferred by 28 U.S.C. § 515, charges:

COUNT 1
(Conspiracy to Commit Health Care Fraud)

1. Unless otherwise indicated, at all times relevant to this Information:

Relevant Individuals and Entities

a. The defendant, KAREEM MEMON (“MEMON”), was a resident

of Florida who owned, operated, and/or had a financial or controlling interest in

entities (the “MEMON Supply Companies”) through which he and his coconspirators

generated information and documents amounting to a guarantee that durable

medical equipment (“DME”) would be reimbursed by Medicare, referred to herein as

a “completed doctor’s order.” As that term was used during MEMON’s scheme, a

completed “doctor’s order” (“DO”) was comprised of a prospective patient’s name,

contact information, insurance information, and a doctor’s order or prescription for a
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 7 of 21

DME orthotic brace, such as a knee, ankle, back, wrist, or shoulder brace for that

particular patient.

b. Aaron Williamsky (“WILLIAMSKY”) and Nadia Levit (“LEVIT”),

coconspirators not charged herein, were residents of New Jersey who owned,

operated, and/or had a financial or controlling interest in several DME supply

companies (the “WILLIAMSKY/LEVIT DME Companies”), which primarily supplied

DME to Medicare beneficiaries. The WILLIAMSKY/LEVIT DME Companies were

enrolled with Medicare as suppliers of DME, and therefore, were authorized to bill

Medicare for the supplying of orthotic braces. Pursuant to the requirements described

above, the WILLIAMSKY/LEVIT DME Companies were also responsible for

acknowledging that any claims made to Medicare complied with the relevant laws,

regulations, and program instructions.

c. Charles Burruss (“BURRUSS”) and Armani Adams (“ADAMS”),

coconspirators not charged herein, were residents of California who owned, operated,

and/or had a financial or controlling interest in several DME supply companies (the

“BURRUSS/ADAMS DME Companies”), which primarily supplied DME to Medicare

beneficiaries. The BURRUSS/ADAMS DME Companies were enrolled with Medicare

as suppliers of DME, and therefore, were authorized to bill Medicare for the supplying

of orthotic braces. Pursuant to the requirements described above, the

BURRUSS/ADAMS DME Companies were also responsible for acknowledging that

any claims made to Medicare complied with the relevant laws, regulations, and

program instructions. The WILLIAMSKY/LEVIT DME Companies and the

2
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 8 of 21

BURRUSS/ADAMS DME Companies will be referred to collectively as the “Subject

DME Companies.”

d. As described more fully below, MEMON entered into

arrangements with WILLIAMSKY, LEVIT, BURRUSS, ADAMS, and others whereby

the Subject DME Companies paid kickbacks and bribes to the MEMON Supply

Companies in exchange for the MEMON Supply Companies providing them with

completed DOs for DME, which the Subject DME Companies would thereafter bill to

and be reimbursed by Medicare and other health care benefit programs, without

regard for medical necessity.

Background on the Medicare Program

e. Medicare was a federally funded program established to provide

medical insurance benefits for individuals aged 65 and older and certain disabled

individuals who qualified under the Social Security Act. Individuals who receive

benefits under Medicare were referred to as “Medicare beneficiaries.”

f. Medicare was administered by the Center for Medicare and

Medicaid Services (“CMS”), a federal agency under the United States Department of

Health and Human Services.

g. Medicare was divided into four parts, which helped cover specific

services: Part A (hospital insurance), Part B (medical insurance), Part C (Medicare

Advantage), and Part D (prescription drug coverage).

3
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 9 of 21

h. Medicare Part B covered non-institutional care that included

physician services and supplies, such as DME that were needed to diagnose or treat

medical conditions and that met accepted standards of medical practice.

i. Medicare was a “health care benefit program,” as defined by 18

U.S.C. § 24(b), and a “Federal health care program,” as defined by 42 U.S.C. § 1320a-

7b(f), that affected commerce.

j. In order for a supplier of DME services to bill Medicare Part B,

that supplier had to enroll with Medicare as a Durable Medical Equipment,

Prosthetics, Orthotics, and Supplies (“DMEPOS”) supplier by completing a Form

CMS-855S.

k. As provided in the Form CMS-855S, to enroll as a DMEPOS

supplier, every DMEPOS supplier had to meet certain standards to obtain and retain

billing privileges to Medicare, such as, but not limited to, the following: (i) provide

complete and accurate information on the Form CMS-855S, with any changes to the

information on the form reported within 30 days; (ii) disclose persons and

organizations with ownership interests or managing control; (iii) abide by applicable

Medicare laws, regulations and program instructions, such as, but not limited to, the

Federal Anti-Kickback Statute (“AKS”) (42 U.S.C. § 1320a-7b(b)); (iv) acknowledge

that the payment of a claim by Medicare was conditioned upon the claim and the

underlying transaction complying with such laws, regulations and program

instructions; and (v) refrain from knowingly presenting or causing to be presented a

4
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 10 of 21

false or fraudulent claim for payment by Medicare and submitting claims with

deliberate ignorance or reckless disregard of their truth or falsity.

TRICARE

l. TRICARE was a health care program of the U.S. Department of

Defense (“DoD”) Military Health System that provided coverage for DoD beneficiaries

worldwide, including active-duty service members, National Guard and Reserve

members, retirees, their families, and survivors. The Defense Health Agency, an

agency of the DoD, was the military entity responsible for overseeing and

administering the TRICARE program.

m. TRICARE was a “health care benefit program,” as defined by 18

U.S.C. § 24(b), and a “Federal health care program,” as defined by 42 U.S.C. § 1320a-

7b(f), that affected commerce.

CHAMPVA

n. The Civilian Health and Medical Program of the Department of

Veterans Affairs (“CHAMPVA”) was a federal health care benefit program within the

Department of Veterans Affairs (“VA”). CHAMPVA was a comprehensive health care

program in which the VA shared the cost of covered health care services and supplies

with eligible beneficiaries. The eligible categories for CHAMPVA beneficiaries were

the spouses or children of veterans who had been rated permanently and totally

disabled for a service-connected disability and the surviving spouse or child of a

veteran who died from a VA-rated service-connected disability.

5
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 11 of 21

o. In general, the CHAMPVA program covered most health care

services and supplies that were medically and psychologically necessary. CHAMPVA

was always the secondary payer to Medicare and reimbursed beneficiaries for costs

that Medicare did not cover. Health care claims had to have first been sent to

Medicare for processing. Medicare electronically forwarded claims to CHAMPVA

after Medicare had processed them.

p. CHAMPVA was a “health care benefit program,” as defined by 18

U.S.C. § 24(b), and a “Federal health care program,” as defined by 42 U.S.C. § 1320a-

7b(f), that affected commerce.

Telemedicine

q. Telemedicine allowed health care providers to evaluate, diagnose,

and treat patients remotely—without the need for an in-person visit—by using

telecommunications technology, such as the internet or telephone, to interact with a

patient.

r. Medicare deemed telemedicine an appropriate means to provide

certain health care related services (“telehealth services”) to beneficiaries, including,

among other services, consultations, and office visits, only when certain requirements

were met. These requirements included, among others, that: (i) the beneficiary was

located in a rural area (outside a metropolitan area or in a rural health professional

shortage area); (ii) the services were delivered via an interactive audio and video

telecommunications system; and (iii) the beneficiary was at a licensed provider’s

6
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 12 of 21

office or a specified medical facility—not at a beneficiary’s home—during the

telehealth service furnished by a remote provider.

s. Telehealth services could be covered by and reimbursable under

Medicare, but only if telemedicine was generally appropriate, as outlined above, and

only if the services were both ordered by a licensed provider and were reasonable and

medically necessary to diagnose and treat a covered illness or condition.

The Conspiracy

2. From in or around 2017 through in or around 2020, in the District of

New Jersey, and elsewhere, defendant

KAREEM MEMON

did knowingly and intentionally conspire and agree with others to knowingly and

willfully execute a scheme and artifice to defraud a health care benefit program and

to obtain, by means of false and fraudulent pretenses, representations, and promises,

money owned by, and under the custody and control of, a health care benefit program,

as defined by 18 U.S.C. § 24(b), namely, Medicare, in connection with the delivery of

and payment for health care benefits, items, and services, contrary to Title 18, United

States Code, Section 1347.

Goal of the Conspiracy

3. The goal of the conspiracy was for MEMON and others to obtain money

by submitting or causing the submission of false and fraudulent claims to Medicare

and other federal and private health care benefit programs.

7
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 13 of 21

Manner and Means

4. The manner and means by which MEMON and others sought to

accomplish the object of the conspiracy included, among other things, the following:

a. From in or around February 2015 through in or around April

2019, WILLIAMSKY, LEVIT, BURRUSS, ADAMS and others began purchasing and

establishing DME companies, including the Subject DME Companies, in New Jersey,

New York, and elsewhere to fraudulently bill health care benefit programs, including

Medicare, for various orthotic braces.

b. Through the Subject DME Companies, and/or other billing

companies, WILLIAMSKY, LEVIT, BURRUSS, ADAMS, and others submitted

and/or caused the submission of false or fraudulent claims to Medicare and other

federal and private health care benefit programs for orthotic braces that were: (i) not

medically necessary; (ii) never requested by a Medicare beneficiary; (iii) never

received by a Medicare beneficiary; and/or (iv) provided based on a DO procured

through the payment of kickbacks and bribes.

c. From in or around 2017 through in or around 2020, the Subject

DME Companies entered into kickback agreements with a number of individuals and

entities who were able to generate completed DOs (the “DME Suppliers”). The Subject

DME Companies paid the DME Suppliers, including MEMON, kickbacks ranging

from approximately $125 to $450 for each completed DO.

d. MEMON and others sold completed DOs from the MEMON

Supply Companies to the Subject DME Companies, and others, located in New Jersey

8
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 14 of 21

and elsewhere.

e. In general, the DME Suppliers obtained completed DOs for DME

for beneficiaries located in the United States and elsewhere through the use of

marketing call centers and telemedicine companies with whom they had

relationships.

f. To conceal the payment of kickbacks, the Subject DME

Companies entered into sham “Marketing, Business Process Outsourcing and Call

Center” agreements (“Marketing Agreements”) with the DME Suppliers. On paper,

the Marketing Agreements called for the DME Suppliers to provide “raw leads”

generated from various advertising campaigns for orthotic braces to the Subject DME

Companies. According to the agreements, these raw leads were to consist only of

information of individuals responding to the advertisements indicating an interest in

orthotic braces. In reality, the DME Suppliers provided WILLIAMSKY, LEVIT,

BURRUSS, ADAMS, and others affiliated with their DME Companies with

completed DOs and not “raw leads.”

g. Once the Subject DME Companies received the completed DOs

from the DME Suppliers, they arranged for the shipping of the ordered orthotic

brace(s) to the beneficiary and electronically submitted and/or caused the electronic

9
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 15 of 21

submission of a claim to Medicare and other federal and private health care benefit

programs for payment.

h. Based on the submission of these claims, the Subject DME

Companies received from Medicare and other federal and private health care benefit

programs payments that they were not entitled to receive.

i. As a result of MEMON’s participation in the health care fraud

kickback scheme, from in or around 2017 through in or around 2020, MEMON and

his coconspirators caused a loss to Medicare of approximately $11,384,001.

In violation of Title 18, United States Code, Section 1349.

10
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 16 of 21

COUNT 2
(Conspiracy to Violate the Federal Anti-Kickback Statute)

1. The allegations in Paragraphs 1 and 3 through 5 of Count 1 are re-

alleged here.

2. From in or around February 2017 through in or around 2020, in the

District of New Jersey, and elsewhere, defendant

KAREEM MEMON

did knowingly and intentionally conspire and agree with others to commit an offense

against the United States, that is, to knowingly and willfully solicit and receive

remuneration, directly and indirectly, overtly and covertly, in cash and in kind, that

is, kickbacks and bribes, from any person in return for purchasing, ordering, and

arranging for, and recommending purchasing and ordering, any good, item, and

service, namely, durable medical equipment, for which payment may be made in

whole and in part under a Federal health care program, as defined by 18 U.S.C. §

24(b), namely, Medicare, TRICARE, and CHAMPVA, contrary to Title 42, United

States Code, Section 1320a-7b(b)(1)(B).

Goal of the Conspiracy

3. The goal of the conspiracy was for MEMON and his coconspirators to

unlawfully enrich themselves by soliciting and receiving kickbacks and bribes for the

referral of Medicare beneficiaries for DME to the Subject DME Companies and

others, for which the DME companies billed to and obtained payments from Medicare

and other federal health care benefit programs.

11
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 17 of 21

Manner and Means

4. The manner and means by which MEMON and others sought to

accomplish the object of the conspiracy included, among other things, the following:

a. As described in Paragraphs 3 through 5 of Count 1, MEMON

entered into kickback arrangements with WILLIAMSKY, LEVIT, BURRUSS,

ADAMS, and others. Pursuant to those arrangements, MEMON and his

coconspirators solicited and received kickbacks for each DO for DME provided to the

Subject DME Companies. To conceal the payment of kickbacks, the Subject DME

Companies entered into sham Marketing Agreements with MEMON and others.

b. As a result of MEMON’s participation in the health care fraud

and kickback scheme, from in or around 2017 through in or around 2020, MEMON

and his coconspirators caused a loss to Medicare and other federal health care benefit

programs of at least approximately $11,384,001.

c. From in or around February 2017 through in or around 2020,

MEMON, through the MEMON Supply Companies) received kickbacks of

approximately $1,486,261.78 for completed DOs provided pursuant to the conspiracy.

Overt Acts

5. In furtherance of the conspiracy and to effect its object, MEMON and

others committed or caused the commission of the following overt acts in the District

of New Jersey and elsewhere:

a. On or about April 9, 2018, WILLIAMSKY and LEVIT, based in

New Jersey, caused a WILLIAMSKY/LEVIT holding company based in New Jersey

12
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 18 of 21

to provide MEMON kickbacks of approximately $36,000 in exchange for completed

DOs for DME.

b. On or about April 10, 2018, WILLIAMSKY and LEVIT, based in

New Jersey, caused a WILLIAMSKY/LEVIT holding company based in New Jersey

to provide MEMON kickbacks of approximately $36,000 in exchange for completed

DOs for DME.

In violation of Title 18, United States Code, Section 371.

13
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 19 of 21

FORFEITURE ALLEGATIONS

1. Upon conviction of the offenses alleged in Counts 1 and 2 of this

Information, defendant KAREEM MEMON shall forfeit to the United States,

pursuant to 18 U.S.C. § 982(a)(7), all property, real or personal, that constitutes or is

derived, directly and indirectly, from gross proceeds traceable to the commission of

the federal health care offenses (as defined by 18 U.S.C. § 24(a)) alleged in this

Information, which was approximately $1,486.261.78.

SUBSTITUTE ASSETS PROVISION
(Applicable to All Forfeiture Allegations)

2. If any of the above-described forfeitable property, as a result of any act

or omission of the defendant:

(a) cannot be located upon the exercise of due diligence;

(b) has been transferred or sold to, or deposited with, a third person;

(d) has been substantially diminished in value; or

(e) has been commingled with other property which cannot be

subdivided without difficulty;

14
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 20 of 21

the United States shall be entitled to forfeiture of substitute property, pursuant to 21

U.S.C. § 853(p), as incorporated by 18 U.S.C. § 982(b).

__________________________
VIKAS KHANNA
Attorney for the United States,
Acting Under Authority Conferred
By 28 U.S.C. § 515

15
Case 0:24-cr-60004-RS Document 1 Entered on FLSD Docket 01/11/2024 Page 21 of 21

CASE NUMBER: 24-17(MEF)
═════════════════════════════════
United States District Court
District of New Jersey
═════════════════════════════════
UNITED STATES OF AMERICA

KAREEM MEMON

═════════════════════════════════
INFORMATION FOR
18 U.S.C. § 1349
18 U.S.C. § 371

═════════════════════════════════
VIKAS KHANNA
ATTORNEY FOR THE UNITED STATES
ACTING UNDER AUTHORITY CONFERRED
BY 28 U.S.C. § 515
NEWARK, NEW JERSEY
═════════════════════════════════
MATTHEW SPECHT
ASSISTANT U.S. ATTORNEY
NEWARK, NEW JERSEY
(973) 353-6061
═════════════════════════════════

File and source

File: 1-rule-20-transfer-packet-incl-d-n-j-information-crim-no-24-17.pdf
Size: 1,134,502 bytes
SHA-256: bf666ddf5ab4b443d7b3948b572e8275ceb9c687e3493fab75b21389745fe922
Our copy: 1-rule-20-transfer-packet-incl-d-n-j-information-crim-no-24-17.pdf
Original: archive.org